Home Industries Market Insights About Us Publisher Contact us

Rosuvastatin Market Size, Share & Trends Analysis Report By Type (purity 98.0%, 99.0%, and others), by Delivery Mode (Parenteral, Oral, And Others), By Treatment (treatment of stroke, obesity, treatment in pancreatitis, and others), by Distribution Channel (Retail Pharmacies/ Drug Stores, Hospital Pharmacies, Online Stores, And Others), Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America)—Forecast till 2028

Categories: Life Science

Formate :

Rosuvastatin belongs to a group of drugs known as “statins”.  Rosuvastatin is available under the brand name “Crestor”. Under the brand name of Crestor, Rosuvastatin is a lipid-lowering blockbuster drug in the world with a sales value of over USD 6 billion in 2012. Along with proper diet and exercise, Rosuvastatin can be used to decrease the level of low-density lipoproteins (LDL) also known as bad cholesterol and fats (triglycerides), and increase the level of good cholesterol in the blood. By raising the level of high-density lipoproteins (HDL) also known as good cholesterol and lowering the level of bad cholesterol in the blood helps reduce several cardiovascular diseases such as the risk of stroke, and other types of cardiovascular abnormalities. Rosuvastatin does not have any major side effects, it may sometimes show minor health abnormalities, such as diabetes, nausea, vomiting muscle pain, weakness, trouble in breathing, and others. Therefore, before taking Rosuvastatin medication, patients are suggested to consult a doctor.

 

The global Rosuvastatin market size is expected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of 3.6 % during 2021-2026.

 

The global Rosuvastatin market is primarily driven by rising population across the world, growing prevalence of obesity and awareness about the negative outcomes of obesity, and developing health care infrastructure. Also, stringent regulatory conditions and intellectual property rights are likely to hamper the growth of the global rosuvastatin market. However, accessibility of generic products, competition among generic and brand companies is expected to open opportunities for the global rosuvastatin market. In addition, R&D investments by major players in the pharmaceutical industry are anticipated to generate growth opportunities for the global Rosuvastatin market in the near future.

 

The global Rosuvastatin market is segmented based on type, delivery mode, treatment, distribution channel, and application. Based on type the global Rosuvastatin is segmented into purity 98.0%, 99.0%, and others. Based on the delivery mode the global Rosuvastatin market is segmented into parenteral, oral, and others. In terms of treatment, the global Rosuvastatin is segmented into the treatment of stroke, obesity, treatment in pancreatitis, and others. The treatment of the obesity segment dominates the global Rosuvastatin market. By distribution channel, the global Rosuvastatin market is segmented into retail pharmacies/ drug stores, hospital pharmacies, online stores, and others. Based on application the global Rosuvastatin market is segmented into tablets, capsules, and others. In application, the oral segment occupies a major share of the global Rosuvastatin market.

 

Geographically, the global Rosuvastatin market is segmented into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South America. The pervasiveness of obesity in North America was projected at 40.0% in 2017 and Canada was estimated at 20%. North America dominates the global Rosuvastatin market, due to growth in population, preference for non-surgical treatment, the substantial prevalence of obesity, robust health care infrastructure, and rise in awareness of health care in the region. The U.K. has the highest number of obese people in Europe and is followed by France, Germany, Poland, and others. Europe is the second-largest in the global Rosuvastatin market. It is estimated to expand at a significant growth rate owing to an increase in the prevalence of obesity and a high preference for non-surgical treatment. It is anticipated to expand at a significant growth rate during the forecast period due to, generic companies in the region, availability of generic companies, and competition between key market players and large patient population pool, developing medical infrastructure. However, lack of medical awareness and weak medical infrastructure may have a negative impact on the growth of the Rosuvastatin market in Latin America, and Middle East & Africa during the forecast period. 

 

Some of the key players in the global Rosuvastatin market are Sun Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis), Lupin Ltd., Hetero Drugs Ltd., Biocon Ltd., Cadilla Pharmaceuticals, Aurobindo Pharmaceuticals, Apotex Inc., IPR Pharmaceuticals Inc., Watson Labs Inc., Torrent Pharmaceuticals Ltd. and Teva Pharmaceuticals. The major players in the global Rosuvastatin market are investing in manufacturing generic version of the drug to meet the increasing demand of Rosuvastatin. For instance, Sun Pharmaceuticals has launched of Ezallor Sprinkle™ (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have trouble in swallowing the drugs, a problem that is projected to affect about 30-35% of residents.

 

Global Rosuvastatin Market Growth, Trend and Forecast 2021-2027

Chapter 1 Rosuvastatin Market Overview
1.1 Product Overview and Scope of Rosuvastatin
1.2 Rosuvastatin Market Segmentation by Type
1.2.1 Global Production Market Share of Rosuvastatin by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Rosuvastatin Market Segmentation by Application
1.3.1 Rosuvastatin Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Rosuvastatin Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Rosuvastatin (2014-2027)

Chapter 2 Global Economic Impact on Rosuvastatin Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Rosuvastatin Market Competition by Manufacturers
3.1 Global Rosuvastatin Production and Share by Manufacturers (2020 and 2020)
3.2 Global Rosuvastatin Revenue and Share by Manufacturers (2020 and 2020)
3.3 Global Rosuvastatin Average Price by Manufacturers (2020 and 2020)
3.4 Manufacturers Rosuvastatin Manufacturing Base Distribution, Production Area and Product Type
3.5 Rosuvastatin Market Competitive Situation and Trends
3.5.1 Rosuvastatin Market Concentration Rate
3.5.2 Rosuvastatin Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Rosuvastatin Production, Revenue (Value) by Region (2014-2021)
4.1 Global Rosuvastatin Production by Region (2014-2021)
4.2 Global Rosuvastatin Production Market Share by Region (2014-2021)
4.3 Global Rosuvastatin Revenue (Value) and Market Share by Region (2014-2021)
4.4 Global Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.5 North America Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.6 Europe Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.7 China Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.8 Japan Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.9 Southeast Asia Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)
4.10 India Rosuvastatin Production, Revenue, Price and Gross Margin (2014-2021)

Chapter 5 Global Rosuvastatin Supply (Production), Consumption, Export, Import by Regions (2014-2021)
5.1 Global Rosuvastatin Consumption by Regions (2014-2021)
5.2 North America Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)
5.3 Europe Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)
5.4 China Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)
5.5 Japan Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)
5.6 Southeast Asia Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)
5.7 India Rosuvastatin Production, Consumption, Export, Import by Regions (2014-2021)

Chapter 6 Global Rosuvastatin Production, Revenue (Value), Price Trend by Type
6.1 Global Rosuvastatin Production and Market Share by Type (2014-2021)
6.2 Global Rosuvastatin Revenue and Market Share by Type (2014-2021)
6.3 Global Rosuvastatin Price by Type (2014-2021)
6.4 Global Rosuvastatin Production Growth by Type (2014-2021)

Chapter 7 Global Rosuvastatin Market Analysis by Application
7.1 Global Rosuvastatin Consumption and Market Share by Application (2014-2021)
7.2 Global Rosuvastatin Consumption Growth Rate by Application (2014-2021)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Rosuvastatin Manufacturing Cost Analysis
8.1 Rosuvastatin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Rosuvastatin

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Rosuvastatin Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Rosuvastatin Major Manufacturers in 2020
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Rosuvastatin Market Forecast (2021-2027)
12.1 Global Rosuvastatin Production, Revenue Forecast (2021-2027)
12.2 Global Rosuvastatin Production, Consumption Forecast by Regions (2021-2027)
12.3 Global Rosuvastatin Production Forecast by Type (2021-2027)
12.4 Global Rosuvastatin Consumption Forecast by Application (2021-2027)
12.5 Rosuvastatin Price Forecast (2021-2027)

Chapter 13 Appendix


 

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

FAQ

Choose License Type

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Personalize this Research

  • Market Size and Share from 2016 - 2027
  • Expected Market Growth Until 2027
  • COVID-19 Impact assessment on the market
  • Market Dynamics and Impact Analysis
  • Segment and region that will drive or lead the market growth and why
  • Industry activity comprising Mergers, Acquisitions, Expansion, etc.
  • Comprehensive Mapping of the Competitive Landscape
  • In-depth analysis of key sustainability strategies adopted by market players
  • Global and regional market trends – Current and Future
  • Value Chain Analysis
  • Porters Five Forces Analysis
  • Historical and Current Product Pricing
  • Country Cross-Segment Analysis
  • Company Profiling
  • Player Comparison Matrix

Life Science Clients

Rosuvastatin Market Size, Share & Trends Analysis ...

RD Code : HP21